Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke patients

Cheryl D. Bushnell, Larry B. Goldstein

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Observational study data have suggested that neurologists preferentially selected younger patients with generally few traditional stroke risk factors for homocysteine testing. The aim of this study was to corroborate observational data by assessing neurologists' reported practices for the detection and treatment of hyperhomocysteinemia in patients with acute ischemic stroke. All academic neurology faculty (n = 49), trainees (neurology residents/fellows, n = 53), and a random sample of community-based neurologists (n = 66) throughout North Carolina were surveyed regarding their homocysteine testing and treatment practices. Nine neurologists were ineligible because they had either retired or moved out of state. A total of 93 of the remaining 159 surveys (58.5%) were completed (response rates: faculty, 74%; trainees, 47%; community-based neurologists, 56%). Patients age < 50 years (n = 52; 63%) and the absence of traditional stroke risk factors (n = 57; 70%) were the most common factors cited as prompting homocysteine testing. The homocysteine level threshold for treatment varied independently by practice type (faculty: median, 14 μmol/L; range, 6-16 μmol/L; trainees: median, 14.5 μmol/L; range, 10-20 μmol/L; community-based: median, 10.4 μmol/L; range, 7-15 μmol/L; P =. 01), the number of stroke patients evaluated during a typical week (Spearman's r =. 32; P =. 034), and year of training completion (Spearman's r =. 41; P =. 003). About half (51%) treat elevated homocysteine with a combination of folate, vitamin B12, and vitamin B6. Consistent with observational data, the majority of the neurologists surveyed report that they select young stroke patients who lack traditional stroke risk factors for homocysteine testing. Thresholds for treatment varied between community-based and academic neurologists and correlated with the physicians' stroke patient volume.

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalJournal of Stroke and Cerebrovascular Diseases
Volume14
Issue number3
DOIs
StatePublished - May 2005

Bibliographical note

Funding Information:
Supported by National Institutes of Health grant K23 NS41929.

Keywords

  • Diagnostic testing
  • Homocysteine
  • Ischemic stroke
  • Questionnaire

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke patients'. Together they form a unique fingerprint.

Cite this